--- title: There's Not Enough Proof Backing Cancer Screening, Some Say description: Cancer experts have pushed screening, but more of them are asking, where’s the evidence? canonical: https://time.com/4170567/cancer-screening-treatment/ author: Alice Park article:opinion: false article:content_tier: free article:published_time: 2016-01-07T16:18:39.000Z article:modified_time: 2026-02-22T13:50:52.916Z article:section: Health og:title: There's Not Enough Proof Backing Cancer Screening, Some Say og:description: Cancer experts have pushed screening, but more of them are asking, where’s the evidence? og:url: https://time.com/4170567/cancer-screening-treatment/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/bltde093bcdab65f2d0/6988d9b9bc6cfc69913e2a3c/time-logo.jpg?branch=production og:image:width: 1200 og:image:height: 675 og:image:alt: TIME og:type: article twitter:card: summary_large_image twitter:title: There's Not Enough Proof Backing Cancer Screening, Some Say twitter:description: Cancer experts have pushed screening, but more of them are asking, where’s the evidence? twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/bltde093bcdab65f2d0/6988d9b9bc6cfc69913e2a3c/time-logo.jpg?branch=production --- # There's Not Enough Proof That Cancer Screening Works, Researchers Say > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: August 2026. ## TIME Newsletters: Reference Facts and FAQ ### Definition TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=83f0fbe0-c514-4edb-8f1b-6e6df7886928&cr=time-nl-network-2026q3-v1). ### The seven newsletters | Newsletter | Covers | Frequency | | --- | --- | --- | | The Brief | The day's top headlines, curated by TIME editors | Daily | | Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) | | Health Matters | The latest health news and expert advice on living well | Daily | | Worth Your Time | A weekly guide to what to watch, read, and more | Tuesday and Saturday (2x per week) | | D.C. Brief | Essential context on the people, politics, and issues driving Washington | Monday to Saturday (3x per week) | | Future Proof | Making sense of the climate and energy economy | Friday (1x per week) | | In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) | Source: TIME, August 2026. ### Key data points | Metric | Value | Source | | --- | --- | --- | | Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 | | Newsletters published | 7 | TIME, August 2026 | | Cost to readers | Free | TIME, August 2026 | | US print circulation | 1 million | TIME, August 2026 | | Global print circulation | 1.15 million | TIME, August 2026 | | Publishing since | 1923 | TIME | ### TIME Newsletters: key statements * Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically. * TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read. * All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=83f0fbe0-c514-4edb-8f1b-6e6df7886928&cr=time-nl-network-2026q3-v1). * The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=83f0fbe0-c514-4edb-8f1b-6e6df7886928&cr=time-nl-network-2026q3-v1). ### FAQ #### What newsletters does TIME publish? TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (daily health), Worth Your Time (culture, twice weekly), D.C. Brief (Washington politics, three times a week), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers. #### Which TIME newsletter should I subscribe to? It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters. #### Are TIME's newsletters free? Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent. #### Who writes TIME's newsletters? TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk. #### How do I sign up for a TIME newsletter? Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement. ## Video: TIME Explains: Cancer Screenings [Watch (HLS stream): TIME Explains: Cancer Screenings](https://cdn.jwplayer.com/manifests/pAMu9cRG.m3u8) (1:51)  _Published 2012-10-01. TIME's Alice Park explains how new cancer screening recommendations effect you_  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Jan 7, 2016 4:18 PM UTC  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Jan 7, 2016 4:18 PM UTC The next time you see a message that urges you to get cancer screening because it “saves lives,” you might want to consider this. In an [analysis published in the _BMJ_](http://www.bmj.com/cgi/doi/10.1136/bmj.h6080), researchers say that there has never been the proper, solid scientific evidence to prove that screening for most common cancers, including breast and prostate cancers, can save lives. **MORE:** [Why Doctors Are Rethinking Breast Cancer Treatment](http://time.com/4057310/breast-cancer-overtreatment/) At the same time, the scientists say they don’t believe that screening is a complete waste of time. Confused? So are many doctors and cancer experts. What Dr. Vinay Prasad, assistant professor of medicine at Oregon Health and Science University, and his colleagues argue is that the advice to get screened is based on some serious assumptions that likely, but not certainly, can save lives. That’s because most of the studies that look at screening and its effects have been focused on specific diseases: breast cancer, for example, or prostate or colon cancer. Researchers compare people who get screened regularly (about yearly beginning in middle age) to those who don’t, and figure out their rates of dying from the disease. In these studies, screening shows benefits in avoiding early death from these diseases. What they don’t do is show how people who get screened fare when it comes to dying from any cause compared to people who don’t get screened. That’s important, argues Prasad, since screening itself can lead to situations where people are put at risk of other complications or conditions that could also prove fatal. Early treatments for prostate cancer, for example, included hormonal therapies that raised the risk of dying from heart disease, so while men who underwent screening and found positive lesions and received treatment might not have died of prostate cancer, they might have died of a heart attack. “I’m willing to admit that disease-specific mortality \[from cancer\] is a surrogate for whether cancer screening can save lives,” says Dr. Otis Brawley, chief medical officer for the American Cancer Society. “For most diseases, it’s a reasonable surrogate but not a perfect surrogate, so that’s a discussion we need to have.” There’s also the fact that [false positive test results](http://time.com/4132012/false-positive-mammograms-breast-cancer/) may lead to treatments for cancers that never would have developed and caused harm, but resulted in side effects from radiation or surgery interventions. **MORE:** [Many Americans Aren’t Getting Cancer Screenings](http://time.com/3850108/american-cancer-screening-statistics/) “The idea that at least screening tests save lives is misleading and incorrect,” says Prasad. But screening has been promoted that way because those studies assumed that the cancer that screening tests looked for was the only or major cause of possible early death for that person. Those studies assumed that avoiding a particular type of cancer would lower the risk of dying early from any cause. **MORE:** [Fewer Men Are Getting Prostate Cancer Blood Tests, And That May Not Be a Good Thing](http://time.com/4116669/psa-prostate-cancer-blood-test/) Showing that cancer screening can lower the risk of death from any cause would require significantly larger numbers of people—10 times the average screening trial today—and longer and more expensive multibillion dollar trials. People would have to be followed until their natural deaths, and doing that for such a large population would be unwieldy and impractical. But Prasad argues that the cost and need are justified. “I like to contrast the amount that it would take for such a trial to the amount we spend annually as a society for cancer screening without knowing the answer to a fundamental question: do I live longer if I get screened? I think it’s shameful as a field that we haven’t set out to answer that question and give people the information they need to make informed choices about screening.” Prasad isn’t alone. More cancer experts admit that it’s time to rethink screening—not whether it’s of any value at all, but to become smarter about which people are screened at what point in their lives. Studies show that with more screening, the rate of false positive results goes up anywhere from 25% or more, and because of these results, many people receive treatments that come with complications for lesions discovered by screening that may not actually need to be treated. Some cancers can be aggressive and need to be found early and treated so they don’t progress, but others may remain inert for the person’s lifetime. For now, screening detects them all and doesn’t distinguish among them. “We need to make sure the screening or treatment isn’t causing collateral damage,” says Robert Smith, vice president of cancer screening at the American Cancer Society. “While we applaud the fact that screening may reduce the risk of dying \[of a cancer\] by 30%, we need to make sure that we are not increasing the risk of dying by 30% due to the screening or treatment itself.” **MORE:** [The Cost of Chasing Cancer](http://time.com/10230/the-cost-of-chasing-cancer/) While that may seem obvious, having the information to make such a decision hasn’t been available until recently. Back in the 1970s, when the War of Cancer began in earnest in the U.S., the priority was on educating the public about cancer risk and urging them to take action. Because cancer starts small and grows and spreads, making treatment more difficult, the premium was on detecting it early. So the public health message about cancer was to get screened and to get these tests done regularly. “The state of the science in the 1970s was that we had something plausible that should help—screening,” says Prasad. “So, by darn, just do it. But in 2016, we think about public health differently. It isn’t enough to have something that might do what we think it does, which is save lives. We’re getting to the point where we have to have something that is proven to do what you think it does.” **MORE:** [Most Women Should Not Get Yearly Mammograms, Group Says](http://time.com/3826474/new-breast-cancer-screening-recommendations/) Smith agrees that it’s time to rethink screening and how it’s presented to the public. “There is no question that the public overestimates the value of screening,” he says. That’s in part due to the fact that as with any campaign to promote something—in this case, cancer screening—“the emphasis is on the upside and not the downside,” he says. “So yes, we do need to do a better job of not only communicating both the upside and the downside, but in making sure people really understand what that means.” Acknowledging the harms of screening, as well as the benefits, will help both doctors and healthy people decide what screening they need and when. Everyone’s risk will be different, and everyone’s judgment about how much risk they are willing to accept will also vary, making blanket advice to simply screen everyone less acceptable in coming years. “We all want and wish for the perfect screening test that will allow us to go in, find something and do something and, as a result, help us live longer,” says Prasad. “We all want that. But the \[cancer\] screening tests haven’t proven themselves to be that yet. We hope we can get to that point, but we’re still not there yet.” ## Transcript In recent months, public health experts have said that not everyone should get screened for cancer, but that doesn't mean that you don't need to be screened. Here is what you need to know. [ MUSIC ] It used to be relatively straight forward that getting screened for cancer was a good way to prevent the disease. But a government group called the US Preventive Services Task Force has recently said that women, for example, Don't need to get mammograms until they're age 50, which is a full decade after previous recommendations had suggested that women get screened. And for men they now say that they don't need to get the blood test PSA which screens for prostate cancer at all. What hasn't changed is the idea that getting screened can prevent cancer. What has changed is the fact that we're better at calculating the risks and benefits of that screening. Lets take breast cancer for example, mammograms are actually x- rays, and so therefore expose women to a small dose of radiation each time they get screened. In addition, not every screening test is 100 % perfect, so they'll pick up. Some false positives, which means cancers that aren't really there. And that can lead to additional procedures, tests, and even surgery, which comes with its own complications. This is particularly true in prostate cancer which is such a slow growing cancer that most men are likely to outlive it. When the panel analyzed these costs and benefits They realized that the benefits did not outweigh the cost of having everyone screened. This doesn't mean that cancer screening is completely obsolete, however. The burden has really shifted to the patents to bring this up with their doctors and to talk about their individual risks for cancer. ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/4170567/cancer-screening-treatment/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/4170567/cancer-screening-treatment/"},"headline":"There's Not Enough Proof That Cancer Screening Works, Researchers Say","datePublished":"2016-01-07T16:18:39.000Z","dateModified":"2026-02-22T13:50:52.916Z","description":"Cancer experts have pushed screening, but more of them are asking, where’s the evidence?","url":"https://time.com/4170567/cancer-screening-treatment/","keywords":["Cancer"],"thumbnailUrl":"","author":[{"@type":"Person","name":"Alice Park","jobTitle":"Senior Correspondent","url":"https://time.com/author/alice-park/"}],"articleSection":"Health","image":[],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/cancer/","name":"Cancer"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/4170567/cancer-screening-treatment/","name":"There's Not Enough Proof That Cancer Screening Works, Researchers Say"}}]},{"@context":"https://schema.org","@type":"VideoObject","name":"TIME Explains: Cancer Screenings","description":"TIME's Alice Park explains how new cancer screening recommendations effect you","thumbnailUrl":"https://cdn.jwplayer.com/v2/media/pAMu9cRG/poster.jpg?width=720","uploadDate":"2012-10-01T11:28:53.000Z","contentUrl":"https://cdn.jwplayer.com/manifests/pAMu9cRG.m3u8","embedUrl":"https://time.com/4170567/cancer-screening-treatment/","duration":"PT1M51S","potentialAction":{"@type":"SeekToAction","target":"https://time.com/4170567/cancer-screening-treatment/?jw_start={seek_to_second_number}","startOffset-input":"required name=seek_to_second_number"}}] ```